Showing results (151-160 of 354) with videos related to
Sort By:
Pageof 36
Surgery|June 1, 1980
Effect of splenectomy upon tumor growth: characterization of splenic tumor-enhancing cells in vivoH Yamagishi, N R Pellis, B D KahanTransplantation|February 12, 1999
Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study GroupB D Kahan, P R Rajagopalan, M HallJournal of the National Cancer Institute|October 1, 1984
Retardation of postsurgical metastases with the use of extracted tumor-specific transplantation antigens and cyclophosphamideS Nomi, N R Pellis, B D KahanCellular Immunology|January 1, 1988
Active specific immunotherapy with extracted tumor-specific transplantation antigen, cyclophosphamide, and adoptive transfer of tumor-specific cytotoxic T-cell clonesK Naito, N R Pellis, B D KahanJournal of Immunology (Baltimore, Md. : 1950)|December 1, 1994
Blocking of heart allograft rejection by intercellular adhesion molecule-1 antisense oligonucleotides alone or in combination with other immunosuppressive modalitiesS M Stepkowski, Y Tu, T P Condon, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1983
Binding of cyclosporine by human lymphocytes and phospholipid vesiclesS J LeGrue, A W Friedman, B D KahanScience (New York, N.Y.)|June 11, 1971
Salt extraction of soluble HL-A antigensR A Reisfeld, M A Pellegrino, B D KahanTransplantation|February 1, 1991
Production of synergistic but nonidentical mechanisms of immunosuppression by rapamycin and cyclosporineP M Kimball, R H Kerman, B D KahanCancer Immunology, Immunotherapy : CII|January 1, 1985
The effect of purification on the immunogenicity of tumor-specific transplantation antigensT L Saunders, B D Kahan, N R PellisTransplantation|January 1, 1990
Sensitivity of intracellular signals responsible for cell cycle progression to cyclosporineP M Kimball, R H Kerman, B D KahanPageof 36